Avenzo Therapeutics | $60,000,000 | (Sep 23, 2025)
Tilt(2) | $7,100,000 | (Sep 23, 2025)
Unit 221B | $5,000,000 | (Sep 23, 2025)
Certified by Founder
Lodge
Asimov
start up
United States
- Boston, Massachusetts
- 07/02/2023
- Series B
- $200,000,000
Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.
- Industry Biotechnology Research
- Website https://www.asimov.com/
- LinkedIn https://www.linkedin.com/company/asimov/about/
Circuit & Chisel | $19,200,000 | (Sep 23, 2025)
Scindo | $5,403,032 | (Sep 23, 2025)
DaltonTx | $5,402,820 | (Sep 23, 2025)
Mycroft | $3,500,000 | (Sep 23, 2025)
TextYess | $2,833,546 | (Sep 23, 2025)
Sunhat | $10,859,404 | (Sep 23, 2025)
Earthmover PBC | $7,200,000 | (Sep 23, 2025)
Titan Exchange | $7,000,000 | (Sep 23, 2025)
Le Walk | $4,100,000 | (Sep 23, 2025)